Manic Fringe anticorps (C-Term)
Aperçu rapide pour Manic Fringe anticorps (C-Term) (ABIN633865)
Antigène
Voir toutes Manic Fringe (MFNG) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- MFNG antibody was raised against the C terminal of MFNG
-
Purification
- Affinity purified
-
Immunogène
- MFNG antibody was raised using the C terminal of MFNG corresponding to a region with amino acids QLLRTAQLPEQVTLSYGVFEGKLNVIKLQGPFSPEEDPSRFRSLHCLLYP
-
-
-
-
Indications d'application
-
WB: 0.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MFNG Blocking Peptide, (ABIN5614739), is also available for use as a blocking control in assays to test for specificity of this MFNG antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MFNG antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- Manic Fringe (MFNG) (MFNG)
-
Autre désignation
- MFNG
-
Sujet
- MFNG is one of the evolutionarily conserved secreted proteins that act in the Notch receptor pathway to demarcate boundaries during embryonic development. This gene is a member of the fringe gene family which also includes Radical and Lunatic fringe. They all encode evolutionarily conserved secreted proteins that act in the Notch receptor pathway to demarcate boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, fringe proteins have a fucose-specific beta1,3 N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling.
-
Poids moléculaire
- 36 kDa (MW of target protein)
-
Pathways
- Signalisation Notch
Antigène
-